GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 729 filers reported holding GLAXOSMITHKLINE PLC in Q1 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,485,000 | -2.9% | 36,618 | -3.4% | 0.58% | -4.9% |
| Q4 2015 | $1,530,000 | +4.9% | 37,918 | 0.0% | 0.61% | +1.0% |
| Q3 2015 | $1,458,000 | +13.6% | 37,918 | +23.0% | 0.61% | +23.9% |
| Q2 2015 | $1,284,000 | -24.1% | 30,818 | -16.0% | 0.49% | -18.2% |
| Q1 2015 | $1,692,000 | +6.8% | 36,673 | -1.1% | 0.60% | +8.7% |
| Q4 2014 | $1,585,000 | -7.4% | 37,073 | -0.5% | 0.55% | -11.4% |
| Q3 2014 | $1,712,000 | -29.7% | 37,243 | -18.2% | 0.62% | -26.3% |
| Q2 2014 | $2,436,000 | +0.1% | 45,543 | 0.0% | 0.84% | -3.3% |
| Q1 2014 | $2,433,000 | -0.5% | 45,543 | -0.5% | 0.87% | +0.6% |
| Q4 2013 | $2,444,000 | +3.6% | 45,781 | -2.7% | 0.87% | -4.6% |
| Q3 2013 | $2,360,000 | +2.9% | 47,038 | +2.5% | 0.91% | -1.7% |
| Q2 2013 | $2,294,000 | – | 45,912 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |